{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:17:31Z","timestamp":1791811051660,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["110-2321-B-010-005, 111-2321-B-A49-004, 111-2314-B-075 -086 -MY3, 111-2321-B-A49-011, and 112-2321-B-075-007"],"award-info":[{"award-number":["110-2321-B-010-005, 111-2321-B-A49-004, 111-2314-B-075 -086 -MY3, 111-2321-B-A49-011, and 112-2321-B-075-007"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["109-2314-B-075 -054 and 110-2314-B-075 -041 -MY3"],"award-info":[{"award-number":["109-2314-B-075 -054 and 110-2314-B-075 -041 -MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW112-TDU-B-211-144001"],"award-info":[{"award-number":["MOHW112-TDU-B-211-144001"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V108C-092, V109C-096, V110C-111, V111C-161, V112C-078, V113C-123, and V112D67-003-MY3"],"award-info":[{"award-number":["V108C-092, V109C-096, V110C-111, V111C-161, V112C-078, V113C-123, and V112D67-003-MY3"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-024-01852-w","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T10:02:41Z","timestamp":1725444161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Idiopathic intracranial hypertension in Asians: a retrospective dual-center study"],"prefix":"10.1186","volume":"25","author":[{"given":"Hsiang-Ting","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Wei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Shiang","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Ling","family":"Fuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Pin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ta","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Wei","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiing-Feng","family":"Lirng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuu-Jiun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"issue":"12","key":"1852_CR1","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrneurol.2012.223","volume":"8","author":"KP Peng","year":"2012","unstructured":"Peng KP, Fuh JL, Wang SJ (2012) High-pressure headaches: idiopathic intracranial hypertension and its mimics. Nat Rev Neurol 8(12):700\u2013710","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1852_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(15)00298-7","volume":"15","author":"KA Markey","year":"2016","unstructured":"Markey KA, Mollan SP, Jensen RH, Sinclair AJ (2016) Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol 15(1):78\u201391","journal-title":"Lancet Neurol"},{"issue":"4","key":"1852_CR3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1177\/0333102421997093","volume":"41","author":"N Raoof","year":"2021","unstructured":"Raoof N, Hoffmann J (2021) Diagnosis and treatment of idiopathic intracranial hypertension. Cephalalgia 41(4):472\u2013478","journal-title":"Cephalalgia"},{"issue":"10","key":"1852_CR4","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/j.1468-1331.2011.03372.x","volume":"18","author":"N Raoof","year":"2011","unstructured":"Raoof N, Sharrack B, Pepper IM, Hickman SJ (2011) The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol 18(10):1266\u20131268","journal-title":"Eur J Neurol"},{"issue":"8","key":"1852_CR5","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/ene.12442","volume":"21","author":"A Kesler","year":"2014","unstructured":"Kesler A, Stolovic N, Bluednikov Y, Shohat T (2014) The incidence of idiopathic intracranial hypertension in Israel from 2005 to 2007: results of a nationwide survey. Eur J Neurol 21(8):1055\u20131059","journal-title":"Eur J Neurol"},{"issue":"10","key":"1852_CR6","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/jnnp-2017-317440","volume":"89","author":"SP Mollan","year":"2018","unstructured":"Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR et al (2018) Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry 89(10):1088\u20131100","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"1852_CR7","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/head.14125","volume":"61","author":"SP Mollan","year":"2021","unstructured":"Mollan SP, Grech O, Sinclair AJ (2021) Headache attributed to idiopathic intracranial hypertension and persistent post-idiopathic intracranial hypertension headache: a narrative review. Headache 61(6):808\u2013816","journal-title":"Headache"},{"issue":"8","key":"1852_CR8","doi-asserted-by":"publisher","first-page":"e1251","DOI":"10.1212\/WNL.0000000000011463","volume":"96","author":"L Miah","year":"2021","unstructured":"Miah L, Strafford H, Fonferko-Shadrach B, Hollinghurst J, Sawhney IM, Hadjikoutis S et al (2021) Incidence, prevalence and Healthcare Outcomes in idiopathic intracranial hypertension: a Population Study. Neurology 96(8):e1251\u20131261","journal-title":"Neurology"},{"issue":"6","key":"1852_CR9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s004150070182","volume":"247","author":"I Yabe","year":"2000","unstructured":"Yabe I, Moriwaka F, Notoya A, Ohtaki M, Tashiro K (2000) Incidence of idiopathic intracranial hypertension in Hokkaido, the northern-most island in Japan. J Neurol 247(6):474","journal-title":"J Neurol"},{"key":"1852_CR10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3389\/fneur.2020.00869","volume":"11","author":"A Ghaffari-Rafi","year":"2020","unstructured":"Ghaffari-Rafi A, Mehdizadeh R, Ko AWK, Ghaffari-Rafi S, Leon-Rojas J (2020) Idiopathic intracranial hypertension in the United States: demographic and socioeconomic disparities. Front Neurol 11:869","journal-title":"Front Neurol"},{"issue":"9403","key":"1852_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHOE Consultation","year":"2004","unstructured":"Consultation WHOE (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9403):157\u2013163","journal-title":"Lancet"},{"issue":"5","key":"1852_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1001\/jama.2012.39","volume":"307","author":"KM Flegal","year":"2012","unstructured":"Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999\u20132010. JAMA 307(5):491\u2013497","journal-title":"JAMA"},{"issue":"8","key":"1852_CR13","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/j.1468-1331.2008.02207.x","volume":"15","author":"TW Kim","year":"2008","unstructured":"Kim TW, Choung HK, Khwarg SI, Hwang JM, Yang HJ (2008) Obesity may not be a risk factor for idiopathic intracranial hypertension in asians. Eur J Neurol 15(8):876\u2013879","journal-title":"Eur J Neurol"},{"issue":"2","key":"1852_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10384-010-0907-9","volume":"55","author":"IH Liu","year":"2011","unstructured":"Liu IH, Wang AG, Yen MY (2011) Idiopathic intracranial hypertension: clinical features in Chinese patients. Jpn J Ophthalmol 55(2):138\u2013142","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"1852_CR15","first-page":"55","volume":"5","author":"JL Smith","year":"1985","unstructured":"Smith JL (1985) Whence pseudotumor cerebri? J Clin Neuroophalmol 5(1):55\u201356","journal-title":"J Clin Neuroophalmol"},{"issue":"6","key":"1852_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaneurol.2014.133","volume":"71","author":"M Wall","year":"2014","unstructured":"Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI et al (2014) The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 71(6):693\u2013701","journal-title":"JAMA Neurol"},{"issue":"Suppl 1","key":"1852_CR17","first-page":"9","volume":"24","author":"Headache Classification Subcommitte","year":"2004","unstructured":"Headache Classification Subcommittee of the International Headache Society (IHS) (2004) The international classification of headache disorders, 2nd edition. Cephalalgia 24(Suppl 1):9\u2013160","journal-title":"Cephalalgia"},{"issue":"13","key":"1852_CR18","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","volume":"81","author":"DI Friedman","year":"2013","unstructured":"Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81(13):1159\u20131165","journal-title":"Neurology"},{"issue":"1","key":"1852_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classifcation Committee of","year":"2018","unstructured":"Headache Classifcation Committee of the International Headache Society (IHS) (2018) The International Classifcation of Headache disorders, 3rd edition. Cephalalgia 38(1):1\u2013211","journal-title":"Cephalalgia"},{"issue":"3","key":"1852_CR20","doi-asserted-by":"publisher","first-page":"333102423115279","DOI":"10.1177\/03331024231152795","volume":"43","author":"JJ Korsbaek","year":"2023","unstructured":"Korsbaek JJ, Jensen RH, Hogedal L, Molander LD, Hagen SM, Beier D (2023) Diagnosis of idiopathic intracranial hypertension: a proposal for evidence-based diagnostic criteria. Cephalalgia 43(3):3331024231152795","journal-title":"Cephalalgia"},{"issue":"10","key":"1852_CR21","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1212\/WNL.33.10.1386","volume":"33","author":"JJ Corbett","year":"1983","unstructured":"Corbett JJ, Mehta M (1983) Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology 33(10):1386\u20131386","journal-title":"Neurology"},{"issue":"9","key":"1852_CR22","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1212\/01.wnl.0000242704.60275.e9","volume":"67","author":"W Whiteley","year":"2006","unstructured":"Whiteley W, Al-Shahi R, Warlow C, Zeidler M, Lueck C (2006) CSF opening pressure: reference interval and the effect of body mass index. Neurology 67(9):1690\u20131691","journal-title":"Neurology"},{"issue":"1","key":"1852_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/0022-510X(93)90084-C","volume":"116","author":"K Radhakrishnan","year":"1993","unstructured":"Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE (1993) Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci 116(1):18\u201328","journal-title":"J Neurol Sci"},{"issue":"2","key":"1852_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jns.2004.05.009","volume":"223","author":"JA Galvin","year":"2004","unstructured":"Galvin JA, Van Stavern GP (2004) Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center. J Neurol Sci 223(2):157\u2013160","journal-title":"J Neurol Sci"},{"key":"1852_CR25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3389\/fneur.2019.00899","volume":"10","author":"F Wang","year":"2019","unstructured":"Wang F, Lesser ER, Cutsforth-Gregory JK, Bhatti MT, Kilgore KP, Hodge DO et al (2019) Population-based evaluation of lumbar puncture opening pressures. Front Neurol 10:899","journal-title":"Front Neurol"},{"issue":"1","key":"1852_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12987-020-00221-4","volume":"17","author":"GA Bateman","year":"2020","unstructured":"Bateman GA, Subramanian GM, Yap SL, Bateman AR (2020) The incidence of obesity, venous sinus stenosis and cerebral hyperaemia in children referred for MRI to rule out idiopathic intracranial hypertension at a tertiary referral hospital: a 10 year review. Fluids Barriers CNS 17(1):59","journal-title":"Fluids Barriers CNS"},{"key":"1852_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/jnnp.45.1.13","volume":"45","author":"L Fris\u00e9n","year":"1982","unstructured":"Fris\u00e9n L (1982) Swelling of the optic nerve head- a staging scheme. J Neurol Neurosurg Psychiatry 45:13\u201318","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"1852_CR28","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1167\/iovs.14-14243","volume":"55","author":"JL Keltner","year":"2014","unstructured":"Keltner JL, Johnson CA, Cello KE, Wall M, Group NIIHS (2014) Baseline visual field findings in the idiopathic intracranial hypertension treatment trial (IIHTT). Invest Ophthalmol Vis Sci 55(5):3200\u20133207","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1852_CR29","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1167\/iovs.15-18626","volume":"57","author":"M Wall","year":"2016","unstructured":"Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL et al (2016) Visual field outcomes for the idiopathic intracranial hypertension treatment trial (IIHTT). Invest Ophthalmol Vis Sci 57(3):805\u2013812","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"1852_CR30","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1177\/0333102413484095","volume":"33","author":"J Hoffmann","year":"2013","unstructured":"Hoffmann J, Huppertz HJ, Schmidt C, Kunte H, Harms L, Klingebiel R et al (2013) Morphometric and volumetric MRI changes in idiopathic intracranial hypertension. Cephalalgia 33(13):1075\u20131084","journal-title":"Cephalalgia"},{"issue":"3","key":"1852_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/WNO.0000000000000767","volume":"39","author":"RM Mallery","year":"2019","unstructured":"Mallery RM, Rehmani OF, Woo JH, Chen YJ, Reddi S, Salzman KL et al (2019) Utility of Magnetic Resonance Imaging Features for improving the diagnosis of idiopathic intracranial hypertension without Papilledema. J Neuroophthalmol 39(3):299\u2013307","journal-title":"J Neuroophthalmol"},{"issue":"9","key":"1852_CR32","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1212\/01.WNL.0000066683.34093.E2","volume":"60","author":"RI Farb","year":"2003","unstructured":"Farb RI, Vanek I, Scott JN, Mikulis DJ, Willinsky RA, Tomlinson G et al (2003) Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60(9):1418\u20131424","journal-title":"Neurology"},{"issue":"3","key":"1852_CR33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3174\/ajnr.A5055","volume":"38","author":"PP Morris","year":"2017","unstructured":"Morris PP, Black DF, Port J, Campeau N (2017) Transverse sinus stenosis is the most sensitive MR Imaging correlate of idiopathic intracranial hypertension. AJNR Am J Neuroradiol 38(3):471\u2013477","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"1852_CR34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/archophthalmol.2010.94","volume":"128","author":"CJ Scott","year":"2010","unstructured":"Scott CJ, Kardon RH, Lee AG, Fris\u00e9n L, Wall M (2010) Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol 128(6):705\u2013711","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"1852_CR35","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1167\/iovs.15-16465","volume":"56","author":"WS Fischer","year":"2015","unstructured":"Fischer WS, Wall M, McDermott MP, Kupersmith MJ, Feldon SE, Group NIIHS (2015) Photographic Reading Center of the idiopathic intracranial hypertension treatment trial (IIHTT): methods and baseline results. Invest Ophthalmol Vis Sci 56(5):3292\u20133303","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1852_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s10194-018-0919-2","volume":"19","author":"J Hoffmann","year":"2018","unstructured":"Hoffmann J, Mollan SP, Paemeleire K, Lampl C, Jensen RH, Sinclair AJ (2018) European headache federation guideline on idiopathic intracranial hypertension. J Headache Pain 19(1):93","journal-title":"J Headache Pain"},{"issue":"1","key":"1852_CR37","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/s41598-020-58080-w","volume":"10","author":"Q Chen","year":"2020","unstructured":"Chen Q, Feng C, Zhao G, Chen W, Wang M, Sun X et al (2020) Pseudotumour Cerebri Syndrome in China: a Cohort Study. Sci Rep 10(1):1222","journal-title":"Sci Rep"},{"issue":"1","key":"1852_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000435919","volume":"45","author":"G McCluskey","year":"2015","unstructured":"McCluskey G, Mulholland DA, McCarron P, McCarron MO (2015) Idiopathic intracranial hypertension in the Northwest of Northern Ireland: Epidemiology and Clinical Management. Neuroepidemiology 45(1):34\u201339","journal-title":"Neuroepidemiology"},{"issue":"2","key":"1852_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/WNO.0000000000001680","volume":"43","author":"A Eshtiaghi","year":"2023","unstructured":"Eshtiaghi A, Margolin EA, Micieli JA (2023) Idiopathic intracranial hypertension and socioeconomic status in the Greater Toronto Area, Canada. J Neuroophthalmol 43(2):197\u2013201","journal-title":"J Neuroophthalmol"},{"issue":"5","key":"1852_CR40","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2017.01.006","volume":"124","author":"KP Kilgore","year":"2017","unstructured":"Kilgore KP, Lee MS, Leavitt JA, Mokri B, Hodge DO, Frank RD et al (2017) Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity. Ophthalmology 124(5):697\u2013700","journal-title":"Ophthalmology"},{"issue":"2","key":"1852_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1526-4610.2008.01324.x","volume":"49","author":"KB Digre","year":"2009","unstructured":"Digre KB, Nakamoto BK, Warner JE, Langeberg WJ, Baggaley SK, Katz BJ (2009) A comparison of idiopathic intracranial hypertension with and without papilledema. Headache 49(2):185\u2013193","journal-title":"Headache"},{"issue":"1","key":"1852_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1212\/WNL.51.1.245","volume":"51","author":"SJ Wang","year":"1998","unstructured":"Wang SJ, Silberstein SD, Patterson S, Young WB (1998) Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology 51(1):245\u2013249","journal-title":"Neurology"},{"issue":"1","key":"1852_CR43","first-page":"155","volume":"114","author":"M Wall","year":"1991","unstructured":"Wall M, George D (1991) Idiopathic intracranial hypertension: a prospective study of 50 patients. Brain 114(1):155\u2013180","journal-title":"Brain"},{"issue":"6","key":"1852_CR44","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/life11060472","volume":"11","author":"SP Mollan","year":"2021","unstructured":"Mollan SP, Chong YJ, Grech O, Sinclair AJ, Wakerley BR (2021) Current perspectives on idiopathic intracranial hypertension without papilloedema. Life 11(6):472","journal-title":"Life"},{"key":"1852_CR45","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.3389\/fneur.2018.01090","volume":"9","author":"F Bono","year":"2018","unstructured":"Bono F, Curcio M, Rapisarda L, Vescio B, Bombardieri C, Mangialavori D et al (2018) Cerebrospinal fluid pressure-related features in chronic headache: a prospective study and potential diagnostic implications. Front Neurol 9:1090","journal-title":"Front Neurol"},{"issue":"2","key":"1852_CR46","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2214\/AJR.12.9638","volume":"201","author":"AM Saindane","year":"2013","unstructured":"Saindane AM, Bruce BB, Riggeal BD, Newman NJ, Biousse V (2013) Association of MRI findings and visual outcome in idiopathic intracranial hypertension. AJR Am J Roentgenol 201(2):412\u2013418","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"1852_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s10194-023-01641-x","volume":"24","author":"G Bsteh","year":"2023","unstructured":"Bsteh G, Marik W, Krajnc N, Macher S, Mitsch C, Pruckner P et al (2023) MRI features of idiopathic intracranial hypertension are not prognostic of visual and headache outcome. J Headache Pain 24(1):97","journal-title":"J Headache Pain"},{"issue":"1","key":"1852_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/0972-2327.78044","volume":"14","author":"NN Baheti","year":"2011","unstructured":"Baheti NN, Nair M, Thomas SV (2011) Long-term visual outcome in idiopathic intracranial hypertension. Ann Indian Acad Neurol 14(1):19\u201322","journal-title":"Ann Indian Acad Neurol"},{"issue":"7","key":"1852_CR49","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/aos.13664","volume":"96","author":"CF Hatem","year":"2018","unstructured":"Hatem CF, Yri HM, Sorensen AL, Wegener M, Jensen RH, Hamann S (2018) Long-term visual outcome in a Danish population of patients with idiopathic intracranial hypertension. Acta Ophthalmol 96(7):719\u2013723","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"1852_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/17571472.2010.11493315","volume":"3","author":"TY Wu","year":"2010","unstructured":"Wu TY, Majeed A, Kuo KN (2010) An overview of the healthcare system in Taiwan. Lond J Prim care 3(2):115\u2013119","journal-title":"Lond J Prim care"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01852-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-024-01852-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01852-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T10:02:51Z","timestamp":1725444171000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-024-01852-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1852"],"URL":"https:\/\/doi.org\/10.1186\/s10194-024-01852-w","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocols were approved by the Institutional Review Board of Taipei Veterans General Hospital (TVGH IRB No. 2022-04-005AC, and TCVGH IRB No. CE23493C).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"W.T.C. has received honoraria as a speaker from Allergan\/AbbVie, Hava Bio-Pharma, Orient EuroPharma, Pfizer, and Viatris. He has received research grants from the Taiwan National Science and Technology Council, and Taipei Veterans General Hospital. S.J.W. has received personal fees as an advisor or speaker from AbbVie, Orient EuroPharma, Pfizer, and Percept; and has been the PI in trials sponsored by Allergan\/AbbVie, Lundbeck, Novartis, Pfizer, and Orient EuroPharma. He has received research grants from the Taiwan National Science and Technology Council and Taipei Veterans General Hospital. Y.F.W. has received personal fees as an advisor or a speaker from Allergan\/AbbVie, Boehringer Ingelheim, Chugai, Daiichi-Sankyo, Eli Lilly, Hava Bio-Pharma, Lundbeck, Novartis, Orient EuroPharma, Pfizer, Sanofi, Teva, UCB, and Viatris. He has received research grants from the Taiwan National Science and Technology Council, and Taipei Veterans General Hospital. H.T.H, H.C.C., T.W.H., Y.S.T., J.L.F., S.P.C., W.J.L., Y.W.P., Y.C.L., and J.F.L. reported no relevant disclosure.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}